Merck blood thinner shows mixed results: study

"An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers say. The drug could reduce the risk of dying from a future heart attack or stroke by as much as 20 percent in people who had a previous heart attack, but it also significantly hiked the risk of hemorrhage. (AFP Photo/Tom Mihalek)" title

View the Original article